Beam Therapeutics Inc

XNAS:BEAM

34.79

+1.31 (+3.91%)

7:57:29 PM EDT: $34.89 +0.10 (+0.29%)

Market Cap (Intraday)	3.72B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$15.3 Million
Adjusted EPS	-$1.12

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Beam Therapeutics Inc Stock, XNAS:BEAM

238 Main Street, 9th floor, Cambridge, Massachusetts 02142-1016

United States of America

Phone: +1.857.327.8775

Number of Employees: 483

http://www.beamtx.com

Description

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.